BrainCheck Adds Digital Health Veteran to Board Amid Cognitive Care Expansion
Event summary
- BrainCheck appointed Liz Kwo, MD, MBA, MPH, to its Board of Directors on January 28, 2026.
- Dr. Kwo currently serves as Chief Commercial Officer at Everly Health, overseeing a $100M+ P&L.
- She brings extensive experience in digital health, population health, and healthcare governance.
- BrainCheck’s platform has completed over 640,000 cognitive tests and 14,000 Care Plans to date.
The big picture
BrainCheck’s appointment of Dr. Liz Kwo to its Board of Directors underscores its strategic focus on scaling digital cognitive assessment and care. With the growing burden of cognitive impairment, the company is positioning itself to lead the transformation of early detection and scalable care models. Dr. Kwo’s background in digital health and commercialization will be crucial as BrainCheck expands its reach across clinical and research settings.
What we're watching
- Strategic Expansion
- How Dr. Kwo’s commercialization experience will accelerate BrainCheck’s growth in cognitive care.
- Governance Dynamics
- Whether BrainCheck can leverage Dr. Kwo’s board expertise to navigate regulatory and market challenges.
- Market Positioning
- The pace at which BrainCheck can differentiate itself in the competitive digital health landscape.
Related topics